 | • レポートコード：D005-11201 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニモジピンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ニモジピンの種類別市場規模（カプセル、溶液、錠剤）、用途別市場規模（病院、薬局、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sun Pharm Inds、Arbor Pharms、Heritage Pharms、Bayer Vital GmbH、Bionpharma、Sofgen Pharms、Thepharmanetwork ・地域別グローバル市場分析 2015年-2020年 ・ニモジピンの北米市場（アメリカ、カナダ、メキシコ） ・ニモジピンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニモジピンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニモジピンの南米市場（ブラジル、アルゼンチン） ・ニモジピンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：カプセル、溶液、錠剤 ・用途別分析：病院、薬局、クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nimodipine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nimodipine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nimodipine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nimodipine market has been segmented into
Capsule
Solution
Tablets
By Application, Nimodipine has been segmented into:
Hospital
Pharmacy
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nimodipine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nimodipine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nimodipine market.
The report offers in-depth assessment of the growth and other aspects of the Nimodipine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nimodipine Market Share Analysis
Nimodipine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nimodipine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nimodipine sales, revenue and market share for each player covered in this report.
The major players covered in Nimodipine are:
Sun Pharm Inds
Arbor Pharms
Heritage Pharms
Bayer Vital GmbH
Bionpharma
Sofgen Pharms
Thepharmanetwork
Among other players domestic and global, Nimodipine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nimodipine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nimodipine, with price, sales, revenue and global market share of Nimodipine in 2018 and 2019.
Chapter 3, the Nimodipine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nimodipine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nimodipine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nimodipine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nimodipine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nimodipine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Capsule
1.2.3 Solution
1.2.4 Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Nimodipine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.4 Overview of Global Nimodipine Market
1.4.1 Global Nimodipine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sun Pharm Inds
2.1.1 Sun Pharm Inds Details
2.1.2 Sun Pharm Inds Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sun Pharm Inds SWOT Analysis
2.1.4 Sun Pharm Inds Product and Services
2.1.5 Sun Pharm Inds Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arbor Pharms
2.2.1 Arbor Pharms Details
2.2.2 Arbor Pharms Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arbor Pharms SWOT Analysis
2.2.4 Arbor Pharms Product and Services
2.2.5 Arbor Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Heritage Pharms
2.3.1 Heritage Pharms Details
2.3.2 Heritage Pharms Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Heritage Pharms SWOT Analysis
2.3.4 Heritage Pharms Product and Services
2.3.5 Heritage Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Vital GmbH
2.4.1 Bayer Vital GmbH Details
2.4.2 Bayer Vital GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Vital GmbH SWOT Analysis
2.4.4 Bayer Vital GmbH Product and Services
2.4.5 Bayer Vital GmbH Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bionpharma
2.5.1 Bionpharma Details
2.5.2 Bionpharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bionpharma SWOT Analysis
2.5.4 Bionpharma Product and Services
2.5.5 Bionpharma Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sofgen Pharms
2.6.1 Sofgen Pharms Details
2.6.2 Sofgen Pharms Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sofgen Pharms SWOT Analysis
2.6.4 Sofgen Pharms Product and Services
2.6.5 Sofgen Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thepharmanetwork
2.7.1 Thepharmanetwork Details
2.7.2 Thepharmanetwork Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thepharmanetwork SWOT Analysis
2.7.4 Thepharmanetwork Product and Services
2.7.5 Thepharmanetwork Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nimodipine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nimodipine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nimodipine Manufacturer Market Share in 2019
3.3.2 Top 6 Nimodipine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nimodipine Sales, Revenue and Market Share by Regions
4.1.1 Global Nimodipine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nimodipine Revenue and Market Share by Regions (2015-2020)
4.2 North America Nimodipine Sales and Growth Rate (2015-2020)
4.3 Europe Nimodipine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nimodipine Sales and Growth Rate (2015-2020)
4.5 South America Nimodipine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nimodipine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nimodipine Sales, Revenue and Market Share by Country
5.1.1 North America Nimodipine Sales and Market Share by Country (2015-2020)
5.1.2 North America Nimodipine Revenue and Market Share by Country (2015-2020)
5.2 United States Nimodipine Sales and Growth Rate (2015-2020)
5.3 Canada Nimodipine Sales and Growth Rate (2015-2020)
5.4 Mexico Nimodipine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nimodipine Sales, Revenue and Market Share by Country
6.1.1 Europe Nimodipine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nimodipine Revenue and Market Share by Country (2015-2020)
6.2 Germany Nimodipine Sales and Growth Rate (2015-2020)
6.3 UK Nimodipine Sales and Growth Rate (2015-2020)
6.4 France Nimodipine Sales and Growth Rate (2015-2020)
6.5 Russia Nimodipine Sales and Growth Rate (2015-2020)
6.6 Italy Nimodipine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nimodipine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nimodipine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nimodipine Revenue and Market Share by Regions (2015-2020)
7.2 China Nimodipine Sales and Growth Rate (2015-2020)
7.3 Japan Nimodipine Sales and Growth Rate (2015-2020)
7.4 Korea Nimodipine Sales and Growth Rate (2015-2020)
7.5 India Nimodipine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nimodipine Sales and Growth Rate (2015-2020)
7.7 Australia Nimodipine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nimodipine Sales, Revenue and Market Share by Country
8.1.1 South America Nimodipine Sales and Market Share by Country (2015-2020)
8.1.2 South America Nimodipine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nimodipine Sales and Growth Rate (2015-2020)
8.3 Argentina Nimodipine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nimodipine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nimodipine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nimodipine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nimodipine Sales and Growth Rate (2015-2020)
9.3 Turkey Nimodipine Sales and Growth Rate (2015-2020)
9.4 Egypt Nimodipine Sales and Growth Rate (2015-2020)
9.5 South Africa Nimodipine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nimodipine Sales and Market Share by Type (2015-2020)
10.2 Global Nimodipine Revenue and Market Share by Type (2015-2020)
10.3 Global Nimodipine Price by Type (2015-2020)
11 Global Nimodipine Market Segment by Application
11.1 Global Nimodipine Sales Market Share by Application (2015-2020)
11.2 Global Nimodipine Revenue Market Share by Application (2015-2020)
11.3 Global Nimodipine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nimodipine Sales, Revenue and Growth Rate (2021-2025)
12.2 Nimodipine Market Forecast by Regions (2021-2025)
12.2.1 North America Nimodipine Market Forecast (2021-2025)
12.2.2 Europe Nimodipine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nimodipine Market Forecast (2021-2025)
12.2.4 South America Nimodipine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nimodipine Market Forecast (2021-2025)
12.3 Nimodipine Market Forecast by Type (2021-2025)
12.3.1 Global Nimodipine Sales Forecast by Type (2021-2025)
12.3.2 Global Nimodipine Market Share Forecast by Type (2021-2025)
12.4 Nimodipine Market Forecast by Application (2021-2025)
12.4.1 Global Nimodipine Sales Forecast by Application (2021-2025)
12.4.2 Global Nimodipine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nimodipine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nimodipine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nimodipine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sun Pharm Inds Basic Information, Manufacturing Base and Competitors
Table 8. Sun Pharm Inds Nimodipine Major Business
Table 9. Sun Pharm Inds Nimodipine Total Revenue (USD Million) (2018-2019)
Table 10. Sun Pharm Inds SWOT Analysis
Table 11. Sun Pharm Inds Nimodipine Product and Services
Table 12. Sun Pharm Inds Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Arbor Pharms Basic Information, Manufacturing Base and Competitors
Table 14. Arbor Pharms Nimodipine Major Business
Table 15. Arbor Pharms Nimodipine Total Revenue (USD Million) (2018-2019)
Table 16. Arbor Pharms SWOT Analysis
Table 17. Arbor Pharms Nimodipine Product and Services
Table 18. Arbor Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Heritage Pharms Basic Information, Manufacturing Base and Competitors
Table 20. Heritage Pharms Nimodipine Major Business
Table 21. Heritage Pharms Nimodipine Total Revenue (USD Million) (2018-2019)
Table 22. Heritage Pharms SWOT Analysis
Table 23. Heritage Pharms Nimodipine Product and Services
Table 24. Heritage Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Vital GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Vital GmbH Nimodipine Major Business
Table 27. Bayer Vital GmbH Nimodipine Total Revenue (USD Million) (2018-2019)
Table 28. Bayer Vital GmbH SWOT Analysis
Table 29. Bayer Vital GmbH Nimodipine Product and Services
Table 30. Bayer Vital GmbH Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bionpharma Basic Information, Manufacturing Base and Competitors
Table 32. Bionpharma Nimodipine Major Business
Table 33. Bionpharma Nimodipine Total Revenue (USD Million) (2018-2019)
Table 34. Bionpharma SWOT Analysis
Table 35. Bionpharma Nimodipine Product and Services
Table 36. Bionpharma Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sofgen Pharms Basic Information, Manufacturing Base and Competitors
Table 38. Sofgen Pharms Nimodipine Major Business
Table 39. Sofgen Pharms Nimodipine Total Revenue (USD Million) (2018-2019)
Table 40. Sofgen Pharms SWOT Analysis
Table 41. Sofgen Pharms Nimodipine Product and Services
Table 42. Sofgen Pharms Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Thepharmanetwork Basic Information, Manufacturing Base and Competitors
Table 44. Thepharmanetwork Nimodipine Major Business
Table 45. Thepharmanetwork Nimodipine Total Revenue (USD Million) (2018-2019)
Table 46. Thepharmanetwork SWOT Analysis
Table 47. Thepharmanetwork Nimodipine Product and Services
Table 48. Thepharmanetwork Nimodipine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Nimodipine Sales by Manufacturer (2018-2019) (MT)
Table 50. Global Nimodipine Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Nimodipine Sales by Regions (2015-2020) (MT)
Table 52. Global Nimodipine Sales Market Share by Regions (2015-2020)
Table 53. Global Nimodipine Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Nimodipine Sales by Countries (2015-2020) (MT)
Table 55. North America Nimodipine Sales Market Share by Countries (2015-2020)
Table 56. North America Nimodipine Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Nimodipine Revenue Market Share by Countries (2015-2020)
Table 58. Europe Nimodipine Sales by Countries (2015-2020) (MT)
Table 59. Europe Nimodipine Sales Market Share by Countries (2015-2020)
Table 60. Europe Nimodipine Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Nimodipine Sales by Regions (2015-2020) (MT)
Table 62. Asia-Pacific Nimodipine Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Nimodipine Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Nimodipine Sales by Countries (2015-2020) (MT)
Table 65. South America Nimodipine Sales Market Share by Countries (2015-2020)
Table 66. South America Nimodipine Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Nimodipine Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Nimodipine Sales by Countries (2015-2020) (MT)
Table 69. Middle East & Africa Nimodipine Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Nimodipine Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Nimodipine Revenue Market Share by Countries (2015-2020)
Table 72. Global Nimodipine Sales by Type (2015-2020) (MT)
Table 73. Global Nimodipine Sales Share by Type (2015-2020)
Table 74. Global Nimodipine Revenue by Type (2015-2020) (USD Million)
Table 75. Global Nimodipine Revenue Share by Type (2015-2020)
Table 76. Global Nimodipine Sales by Application (2015-2020) (MT)
Table 77. Global Nimodipine Sales Share by Application (2015-2020)
Table 78. Global Nimodipine Sales Forecast by Regions (2021-2025) (MT)
Table 79. Global Nimodipine Market Share Forecast by Regions (2021-2025)
Table 80. Global Nimodipine Sales Forecast by Type (2021-2025) (MT)
Table 81. Global Nimodipine Market Share Forecast by Type (2021-2025)
Table 82. Global Nimodipine Sales Forecast by Application (2021-2025)
Table 83. Global Nimodipine Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nimodipine Picture
Figure 2. Global Sales Market Share of Nimodipine by Type in 2019
Figure 3. Capsule Picture
Figure 4. Solution Picture
Figure 5. Tablets Picture
Figure 6. Nimodipine Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Pharmacy Picture
Figure 9. Clinics Picture
Figure 10. Global Nimodipine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Nimodipine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Nimodipine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Nimodipine Sales Market Share by Manufacturer in 2019
Figure 31. Global Nimodipine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Nimodipine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Nimodipine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Nimodipine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Nimodipine Revenue Market Share by Regions in 2018
Figure 39. North America Nimodipine Sales and Growth Rate (2015-2020)
Figure 40. Europe Nimodipine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Nimodipine Sales and Growth Rate (2015-2020)
Figure 42. South America Nimodipine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Nimodipine Sales and Growth Rate (2015-2020)
Figure 44. North America Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Nimodipine Sales Market Share by Countries (2015-2020)
Figure 46. North America Nimodipine Sales Market Share by Countries in 2018
Figure 47. North America Nimodipine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Nimodipine Revenue Market Share by Countries in 2018
Figure 49. United States Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Nimodipine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Nimodipine Revenue Market Share by Countries in 2019
Figure 55. Germany Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Nimodipine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Nimodipine Revenue Market Share by Regions 2019
Figure 63. China Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Nimodipine Sales Market Share by Countries in 2019
Figure 70. South America Nimodipine Revenue Market Share by Countries in 2019
Figure 71. Brazil Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Nimodipine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Nimodipine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Nimodipine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Nimodipine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Nimodipine Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Nimodipine Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Nimodipine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Nimodipine Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Nimodipine Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Nimodipine Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Nimodipine Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Nimodipine Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
プロバイオティクス錠剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Probiotics Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Probiotics Tablets market …- 犬用経口咀嚼錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Oral Chewable Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Oral Chew…
- カプセル内視鏡検査システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Capsule Endoscopy System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 358.7 million by 2025, from USD 263.4 million in 2019. The Capsule Endos…
- 食道ビデオカプセル内視鏡検査の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Esophageal Video Capsule Endoscopy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Esophageal…
- 創部洗浄液の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Wound Irrigation Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wound Irrigation So…